ADDvise board of directors expects that the turnover for 2015 will be in
the range of 160-170 MSEK, excluding acquisitions, with an EBITDA margin
before any acquisition costs of at least 7 %.
The start of the first quarter 2015 has been strong in terms of new
orders and the outlook for ADDvise markets looks favorable also for the
rest of the year. This, in combination with the fact that efficiency
improvements carried out during 2013 and 2014 are starting to show
results, make the board of directors expect a turnover for 2015 in the
range of 160-170 MSEK with an EBITDA margin before any acquisition costs
of at least 7 %.
For further information, please contact:
Rikard Akhtarzand, CEO, +46 765-25 90 71
rikard.akhtarzand@addvisegroup.se
www.addvisegroup.com
About ADDvise Lab Solutions AB
ADDvise Lab Solutions AB (publ) is an expansive group which through its
subsidiaries IM-Medico Svenska AB, KEBO Inredningar Sverige AB, ADDvise
Tillquist AB, Sonesta Medical AB, Sonesta Medical Inc and Surgical
Tables Inc. offers comprehensive solutions in the form of products and
services to healthcare and research facilities. ADDvise Group\'s
customers are located in both the private and public sectors. The
Company\'s share is listed on First North Premier and Mangold
Fondkommission AB, +46 8-503015 50, is the company\'s Certified Adviser
and liquidity provider.
